Signal · Clinical Psychology
Retest effects in serial cognitive testing can mask a year or more of genuine age-related decline
A secondary analysis of a large US trial in 977 community-dwelling older adults finds that retest effects on repeat neuropsychological testing are large enough to offset roughly a year of expected age-related cognitive decline.
A secondary analysis of trial data from 977 community-dwelling older adults in the United States examined how repeated neuropsychological testing affects apparent cognitive change over time Primary Study. Retest effects — improvement in scores attributable simply to prior exposure to the same tests, rather than genuine change — were large enough to offset roughly a year of expected age-related decline across global cognition, executive function and memory.
This is a methodological rather than an intervention finding, derived from a well-characterised, multi-site US trial population. The precise magnitude of the effect may not transfer exactly to other test batteries or populations, but the underlying phenomenon — that repeat testing itself inflates apparent stability or improvement — is a general feature of serial neuropsychological assessment, not one specific to this trial.
The implication is a methodological caution for any service using serial cognitive testing to track decline or treatment response: an apparent year of stability or improvement on repeat testing could reflect the retest effect rather than a genuine clinical signal, and interpretation of serial scores should account for this.
Sources
- Wang Y, Pike JR, Deal JA, et al. Differences in Cognitive Aging Assessments Associated With Retest Effects. JAMA Network Open. 2026;9(8):e2628782. doi:10.1001/jamanetworkopen.2026.28782 PMID 42584890
